EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Quantitative in vitro PET/MRI and kinetic modelling of imaging agent release from a thermoreversible intranasal sol-gel

Abdallah Almahmoud, Arif Gulzar, Brett M Paterson, Harendra S Parekh, Gary J Cowin, Masood Ali, Rebecca R Hawker, Karnaker Reddy Tupally, Viktor Vegh

European Journal of Pharmaceutics and Biopharmaceutics · 2027-01 · 230 · 115268

DOI: 10.1016/j.ejpb.2026.115268 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pharmaceutics and Biopharmaceutics, 2027-01. Verfasst von Abdallah Almahmoud und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Allied Medical Sciences, Faculty of Applied Medical Sciences, Jordan University of Science and Technology, Irbid, Jordan. Die Arbeit nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intranasal phase-transforming thermoresponsive gels can prolong nasal residence and enable controlled release of diagnostic or therapeutic payloads. However, quantitative real-time release characterisation of multimodal imaging probes remains limited. Here, we developed a poloxamer-based sol-gel and established a hybrid PET/MRI framework to quantify the release of PET tracers and an activatable MnO2 nanoflower into simulated nasal fluid. The formulations transformed from solution-to-gel at ∼ 28-29 °C with a storage modulus of 8.2-9.5 kPa attained at typical nasal cavity temperature (34 °C), while maintaining a nasal-compatible pH. PET imaging with an extended time window demonstrated diffusion-dominated release with clear size dependence: ionic [64Cu]Cu2+ reached 30.0 ± 3.0 % cumulative release at ∼42 h, whereas [64Cu]Cu-Sar-OP showed 15.6 ± 3.1 % cumulative release under the same simulated conditions. PEGylated MnO2 nanoflowers exhibited negligible apparent release in simulated nasal fluid without reductant due to the absence of redox-triggered MnO2 dissolution to soluble Mn2+ and electrolyte-induced nanoparticle aggregation trapping, which restricts diffusion out of the gel; but with GSH-supplementation, quantitative T1/T2 mapping enabled relaxivity-calibrated tracking of apparent Mn-equivalent accumulation, reaching 13.9 ± 0.7 % of the nominal loaded Mn (T1-based) at ∼24 h. The cytocompatibility of MnO2 NFs-PEG was also evaluated in an RPMI 2650 human nasal epithelial cell model following 24-h exposure. Kinetic modelling (Higuchi and Korsmeyer - Peppas) supported diffusion-dominated transfer of the PET tracers, whereas the MnO2 profile reflected coupled redox and transport processes under limited-GSH conditions. Overall, our integrated PET/MRI approach provides a quantitative framework for comparing in vitro depot release kinetics and informing intranasal PET/MRI formulation design; however, the findings should not be interpreted as direct evidence of mucosal retention or in vivo nose-to-brain transport.

Schlagwörter

Stichwörter der Autor:innen

Copper-64 radiotracersHybrid PET/MRIIntranasal (nose-to-brain) deliveryRedox-responsive MnO(2)nanoflowersThermoreversiblepoloxamer sol–gel

Autor:innen und Institutionen

  • Department of Allied Medical Sciences, Faculty of Applied Medical Sciences, Jordan University of Science and Technology, Irbid, Jordan.
  • National Imaging Facility, Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, QLD 4072, Australia.
  • ARC Centre for Innovation in Biomedical Imaging Technology, The University of Queensland, Brisbane, QLD 4072, Australia.
  • School of Pharmacy and Pharmaceutical Sciences, The University of Queensland, Brisbane, QLD 4102, Australia.
  • Collaborative Research Platform for NMR Spectroscopy, The University of Queensland, Brisbane, QLD 4072, Australia.
  • ARC Centre for Innovation in Biomedical Imaging Technology, The University of Queensland, Brisbane, QLD 4072, Australia; School of Human Movement and Nutrition Sciences, Faculty of Health, Medicine and Behavioural Scien…

Förderung

  • Australian Research Council

Zitieren

APA

Almahmoud, A., Gulzar, A., Paterson, B. M., Parekh, H. S., Cowin, G. J., Ali, M., Hawker, R. R., Tupally, K. R., & Vegh, V. (2027). Quantitative in vitro PET/MRI and kinetic modelling of imaging agent release from a thermoreversible intranasal sol-gel. European Journal of Pharmaceutics and Biopharmaceutics, 230, 115268. https://doi.org/10.1016/j.ejpb.2026.115268

Vancouver

Almahmoud A, Gulzar A, Paterson BM, Parekh HS, Cowin GJ, Ali M, et al. Quantitative in vitro PET/MRI and kinetic modelling of imaging agent release from a thermoreversible intranasal sol-gel. European Journal of Pharmaceutics and Biopharmaceutics. 2027;230:115268. doi:10.1016/j.ejpb.2026.115268

BibTeX
@article{Almahmoud2027,
  author = {Almahmoud, Abdallah and Gulzar, Arif and Paterson, Brett M and Parekh, Harendra S and Cowin, Gary J and Ali, Masood and Hawker, Rebecca R and Tupally, Karnaker Reddy and Vegh, Viktor},
  title = {Quantitative in vitro PET/MRI and kinetic modelling of imaging agent release from a thermoreversible intranasal sol-gel},
  journal = {European Journal of Pharmaceutics and Biopharmaceutics},
  year = {2027},
  volume = {230},
  pages = {115268},
  doi = {10.1016/j.ejpb.2026.115268}
}
Kostenlos starten →